Ratings on Hornbeck Offshore Services Inc. Raised to 'BB-'; Off Watch, Outlook Stable Aug 04

  • ID: 2085304
  • August 2004
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) August 26, 2004--Standard & Poor's Ratings Services today raised its corporate credit rating and senior unsecured ratings on Hornbeck Offshore Services Inc. to 'BB-'from 'B+' following a review of current and expected growth initiatives and Hornbeck's ability to fund them in a manner that will not hurt credit quality. The ratings were also removed from CreditWatch with positive implications, where they were placed on March 11, 2004, following the announcement that Hornbeck would issue six million shares of common stock in an IPO. The outlook is now stable. Mandeville, La.-based Hornbeck currently has $175 million of debt. "The ratings upgrade reflects Hornbeck's improved liquidity and financial flexibility following its IPO," said Standard & Poor's credit...

Companies mentioned in this report are: Hornbeck Offshore Services Inc.
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Hornbeck Offshore Services Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.